Healthcare provider profile · identity verified

David J. Overley, M.D.

Internal Medicine · LOUISVILLE, KY · NPI 1083679260

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	600	149
Atorvastatin Calcium	Atorvastatin Calcium	540	150
Amlodipine Besylate	Amlodipine Besylate	525	154
Metoprolol Succinate	Metoprolol Succinate	425	112
Pantoprazole Sodium	Pantoprazole Sodium	412	115
Montelukast Sodium	Montelukast Sodium	398	120
Rosuvastatin Calcium	Rosuvastatin Calcium	386	110
Lisinopril	Lisinopril	349	88
Losartan Potassium	Losartan Potassium	278	81
Gabapentin	Gabapentin	274	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	267	55
Furosemide	Furosemide	266	78
Trazodone Hcl	Trazodone Hcl	236	63
Potassium Chloride	Potassium Chloride	193	56
Omeprazole	Omeprazole	191	58
Meloxicam	Meloxicam	189	70
Tamsulosin Hcl	Tamsulosin Hcl	183	57
Eliquis	Apixaban	182	38
Escitalopram Oxalate	Escitalopram Oxalate	182	46
Metformin Hcl	Metformin Hcl	182	50
Ezetimibe	Ezetimibe	180	48
Methylprednisolone	Methylprednisolone	160	118
Simvastatin	Simvastatin	160	45
Clonazepam	Clonazepam	157	27
Alprazolam	Alprazolam	153	31
Zolpidem Tartrate	Zolpidem Tartrate	150	24
Donepezil Hcl	Donepezil Hcl	144	38
Fluticasone Propionate	Fluticasone Propionate	143	53
Metoprolol Tartrate	Metoprolol Tartrate	143	44
Glimepiride	Glimepiride	131	40
Duloxetine Hcl	Duloxetine Hcl	119	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	118	26
Synthroid	Levothyroxine Sodium	117	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	115	32
Hydrochlorothiazide	Hydrochlorothiazide	114	33
Bupropion Xl	Bupropion Hcl	110	30
Buspirone Hcl	Buspirone Hcl	109	17
Mounjaro	Tirzepatide	106	17
Albuterol Sulfate Hfa	Albuterol Sulfate	104	49
Sertraline Hcl	Sertraline Hcl	104	30
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	99	74
Repatha Sureclick	Evolocumab	99	17
Allopurinol	Allopurinol	96	32
Metformin Hcl Er	Metformin Hcl	95	25
Diclofenac Sodium	Diclofenac Sodium	94	41
Raloxifene Hcl	Raloxifene Hcl	94	27
Famotidine	Famotidine	93	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	suppressed
Pravastatin Sodium	Pravastatin Sodium	92	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	86	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	84	27
Hydralazine Hcl	Hydralazine Hcl	81	23
Memantine Hcl	Memantine Hcl	81	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	77	57
Venlafaxine Hcl Er	Venlafaxine Hcl	76	22
Dicyclomine Hcl	Dicyclomine Hcl	73	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	20
Ondansetron Hcl	Ondansetron Hcl	72	24
Clopidogrel	Clopidogrel Bisulfate	71	21
Ozempic	Semaglutide	60	suppressed
Myrbetriq	Mirabegron	59	11
Baclofen	Baclofen	58	19
Atenolol	Atenolol	57	16
Jardiance	Empagliflozin	57	20
Lorazepam	Lorazepam	55	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	54	21
Vitamin D2	Ergocalciferol (Vitamin D2)	54	21
Alendronate Sodium	Alendronate Sodium	52	13
Carvedilol	Carvedilol	52	19
Fenofibrate	Fenofibrate Nanocrystallized	52	14
Ramipril	Ramipril	52	15
Promethazine Hcl	Promethazine Hcl	51	suppressed
Xarelto	Rivaroxaban	51	11
Azithromycin	Azithromycin	50	44
Mupirocin	Mupirocin	50	36
Celecoxib	Celecoxib	49	15
Doxazosin Mesylate	Doxazosin Mesylate	47	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	45	suppressed
Nystatin	Nystatin	44	25
Pregabalin	Pregabalin	44	11
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	14
Amitriptyline Hcl	Amitriptyline Hcl	41	14
Warfarin Sodium	Warfarin Sodium	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	12
Fluconazole	Fluconazole	39	24
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Trulicity	Dulaglutide	36	suppressed
Prednisone	Prednisone	35	22
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	13
Januvia	Sitagliptin Phosphate	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	17
Spironolactone	Spironolactone	33	13
Cephalexin	Cephalexin	32	21
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	15
Valacyclovir	Valacyclovir Hcl	32	12
Finasteride	Finasteride	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Temazepam	Temazepam	27	suppressed
Amoxicillin	Amoxicillin	26	18
Vascepa	Icosapent Ethyl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nitroglycerin	Nitroglycerin	24	13
Primidone	Primidone	24	suppressed
Brilinta	Ticagrelor	21	suppressed
Cefdinir	Cefdinir	21	19
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Estradiol	Estradiol	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Premarin	Estrogens, Conjugated	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Metronidazole	Metronidazole	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Ibuprofen	Ibuprofen	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Colchicine	Colchicine	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	15	13
Valsartan	Valsartan	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Metaxalone	Metaxalone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Folic Acid	Folic Acid	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error